Abbott Announces Supply Agreement For Needlestick Prevention Products
ABBOTT PARK, IL-Abbott Laboratories has signed a supply agreement for VanishPoint needlestick prevention products. VanishPoint products use patented automated retraction technology, which reduces exposure to contaminated needles.
Once a drug injection or blood draw is complete, the needle automatically retracts from the patient into the barrel of the device.
These products will become part of Abbott's Needlestick Prevention Systems product line.
Abbott already provides hospitals and healthcare facilities with VanishPoint blood collection tube holders under an 18-month agreement and VanishPoint retractable syringes as part of a two-year contract.
Abbott's products satisfy new OSHA prevention directives and the Needlestick Safety and Prevention Act, which became law November 2000.
“A Coup Against Science”: Health Groups Decry Kennedy’s Firing of National Vaccine Advisory Panel
June 12th 2025Health leaders are outraged after HHS Secretary Robert F. Kennedy Jr. abruptly fired all 17 members of the CDC’s vaccine advisory panel, calling it a political purge that threatens public trust and vaccine safety.
AHE Exchange Summit 2025 Brings EVS and Infection Prevention Experts Together in Columbus, Ohio
June 9th 2025The Association for the Health Care Environment (AHE) is set to host its largest event of the year—Exchange Summit 2025—from June 8 to 11 in Columbus, Ohio. With over 600 environmental services (EVS) professionals expected to attend, this year’s conference focuses heavily on infection prevention, interdepartmental collaboration, and education that empowers frontline health care support leaders to improve patient safety and operational efficiency.
